Login / Signup

RNA-seq of peripheral blood mononuclear cells of congenital generalized lipodystrophy type 2 patients.

Yen-Hua HuangTzu-Chien SuChung-Hsing WangSiew-Lee WongYin-Hsiu ChienYu-Tai WangWuh-Liang HwuNi-Chung Lee
Published in: Scientific data (2021)
Illumina RNA-seq analysis was used to characterize the whole transcriptomes of peripheral blood mononuclear cells (PBMCs) from patients with congenital generalized lipodystrophy. RNA-seq information for seven patients with type 2 congenital generalized lipodystrophy (CGL2; Berardinelli-Seip congenital lipodystrophy, BSCL2) was obtained and compared with similar information for seven age- and sex-matched healthy control subjects. All seven CGL2 patients carried biallelic pathogenic mutations affecting the BSCL2 gene and had clinical symptoms of varying severity. The findings provide the whole-transcriptome signatures of PBMCs of CGL2 patients, allowing further exploration of gene expression patterns/signatures associated with the various clinical symptoms of patients with this disease.
Keyphrases
  • rna seq
  • single cell
  • gene expression
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • dna methylation
  • autism spectrum disorder
  • patient reported outcomes